Zhaoyun Liu

Department Of Radiation Oncology And Shandong Provincial Key Laboratory Of Precision Oncology, 250117, PR China
Jinan, Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Tamoxifen enhances radiation efficacy by promoting M1 polarization of tumor associated macrophages via JNK/c-JUN pathway.

Tamoxifen enhances radiation efficacy by promoting M1 polarization of tumor associated macrophages via JNK/c-JUN pathway.

Journal: Cancer letters

Published: September 09, 2025

A single-centre, real-world study on the efficacy and recovery of inflammatory cytokine levels of C5 complement inhibitor therapy in patients with paroxysmal nocturnal haemoglobinuria.

A single-centre, real-world study on the efficacy and recovery of inflammatory cytokine levels of C5 complement inhibitor therapy in patients with paroxysmal nocturnal haemoglobinuria.

Journal: British journal of haematology

Published: March 13, 2025

Monocytes from patients with myelodysplastic syndrome inhibit natural killer cell-mediated antitumor function through the CD200/CD200R pathway.

Monocytes from patients with myelodysplastic syndrome inhibit natural killer cell-mediated antitumor function through the CD200/CD200R pathway.

Journal: International immunopharmacology

Published: November 28, 2024

ACT001 inhibits primary central nervous system lymphoma tumor growth by enhancing the anti-tumor effect of T cells.

ACT001 inhibits primary central nervous system lymphoma tumor growth by enhancing the anti-tumor effect of T cells.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 07, 2024

Targeting NKG2D/NKG2DL axis in multiple myeloma therapy.

Targeting NKG2D/NKG2DL axis in multiple myeloma therapy.

Journal: Cytokine & growth factor reviews

Published: January 17, 2024

Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming.

Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming.

Journal: Cancer letters

Published: January 09, 2024

Folic acid-coupled bovine serum albumin-modified magnetic nanocomposites from quantum-sized Fe3O4 and layered double hydroxide for actively targeted delivery of 5-fluorouracil.

Folic acid-coupled bovine serum albumin-modified magnetic nanocomposites from quantum-sized Fe3O4 and layered double hydroxide for actively targeted delivery of 5-fluorouracil.

Journal: International journal of biological macromolecules

Published: August 16, 2023

Construction of pH-responsive polydopamine coated magnetic layered hydroxide nanostructure for intracellular drug delivery.

Construction of pH-responsive polydopamine coated magnetic layered hydroxide nanostructure for intracellular drug delivery.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: September 11, 2022

Self-assembly of X-shaped antibody to combine the activity of IgG and IgA for enhanced tumor killing.

Self-assembly of X-shaped antibody to combine the activity of IgG and IgA for enhanced tumor killing.

Journal: Theranostics

Published: May 09, 2022

Iron overload regulate the cytokine of mesenchymal stromal cells through ROS/HIF-1α pathway in Myelodysplastic syndromes.

Iron overload regulate the cytokine of mesenchymal stromal cells through ROS/HIF-1α pathway in Myelodysplastic syndromes.

Journal: Leukemia research

Published: March 07, 2020

Chidamide shows synergistic cytotoxicity with cytarabine via inducing G0/G1 arrest and apoptosis in myelodysplastic syndromes.

Chidamide shows synergistic cytotoxicity with cytarabine via inducing G0/G1 arrest and apoptosis in myelodysplastic syndromes.

Journal: American journal of translational research

Published: May 03, 2017

A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes.

A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 05, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026